Shire to Buy ViroPharma for Around $4.2 Billion

Shire to Buy ViroPharma for Around $4.2 Billion

In order to establish itself in providing treatments for rare disease, Shire Plc is going to buy ViroPharma Inc. The deal has taken place for around $4.2 billion and Shire will be paying $50 a share and that too in cash.

The recent deal is considered to be the third one for Shire. The purchase will allow Shire to have an access to Cinryze, a medicine meant for the treatment of hereditary angioedema, an inflammatory condition.

The company has said that the deal will help in raising Shire's earnings per share. In fact, as the announcement of the deal was made, Shire was able to witness a rise of 3.5% amounting to 2,894 pence.

"It's a deal that fits with our strategy of increased focus on high-growth speciality markets, particularly rare diseases", said Flemming Ornskov, CEO of Shire.

Ornskov talked about Cinryze and said that it will act a grown engine for the company. Moreover, it is an attractive drug that will prove beneficial for the company.

In addition, it has been revealed that Shire has announced that it has been planning to stop a number of programs that are taking place out of the field of rare disease.


FrenchTribune Specials

Risk of Severe Floods Increases for New York City: Study

Number of factors has significantly increased the risk for New York City to witness severe floods, finds a novel study. Sea level rise, wetlands' damage, dredging of waterways and shift in storm tracks among other factors have made parts of New York to be 20 times more susceptible to floods since mid 1880s.

Now, chance of water crossing...

Most Popular

Drone Technology Used to Unearth New Mexico’s Ancient Village Site

A customized and inexpensive drone helped archaeologists...

World’s Longest-Term Experiment Finally Drops 9th Dollop

The world's longest-term experiment, pitch drop...

$5,000 Reward for Info on Convict Responsible for Injuring California’s Brown Pe

On April 16, in the Belmont Shore area, a pelican was...

Poll

Can Greece Come out of Economic Problems: